Unlocking Answers: Why Genetic Testing Matters in AML Care

Event Description
Join us for an insightful session with Dr. Harry Erba, a renowned expert in AML care, as we uncover the importance of genetic testing in managing AML. Learn how understanding your genetic profile can influence treatment options and improve outcomes. Dr. Erba will simplify complex concepts, empowering you to make informed decisions about your care. Don’t miss this opportunity to gain valuable knowledge and ask your questions directly to one of the leading voices in AML research and treatment.
Schedule & Agenda

Marilu introduces the agenda for the event and featured speaker Harry P. Erba, MD, PhD

Marilu introduces the agenda for the event and featured speaker Harry P. Erba, MD, PhD

Dr. Erba talks about genetic testing for AML

Dr. Erba talks about genetic testing for AML

Type your questions in the chat and we will answer them!

Type your questions in the chat and we will answer them!
Speakers & Moderators

Marilu is an International Medical Graduate passionate about supporting patients and building strong community connections. Since joining HealthTree, she has contributed in roles such as Myeloma Navigator and Patient Navigator, always focused on empowering patients. Now, as Event Operations Manager, she organizes webinars featuring key speakers to address topics relevant to AML and MDS patients and their families. Beyond her work, Marilu is a travel enthusiast and a good listener who enjoys spending time with her family and friends.

Professor of Medicine, Division of Hematologic Malignancies and Cellular Therapy Director, Leukemia Program, Duke University, Durham, NC Chair, SWOG Leukemia Committee Dr Erba is a professor of medicine in the Division of Hematologic Malignancies and Cellular Therapy at Duke University. He serves as the Director of the Leukemia Program. Dr Erba graduated from Yale University with a Bachelor of Science degree in Biology. He earned his medical degree and doctor of philosophy degree in Biophysics from Stanford University School of Medicine in California. He completed his internship, residency and fellowship at Brigham and Women’s Hospital. He has been a clinical investigator for myeloid neoplasms at the University of Michigan (1996-2012), University of Alabama at Birmingham (2012-2018), and Duke University since 2018. He has served as the Chair of the SWOG Leukemia Committee since 2012, member of the NCI Leukemia Steering Committee since 2012, and the Co-Chair of the Senior Scientific Council of the NCI-sponsored MyeloMATCH precision medicine initiative since 2019.
Join the Conversation
This event is part of the Acute Myeloid Leukemia Discussion group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org

Get the Latest Acute Myeloid Leukemia Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.
Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:
